TrialThe Lancet. Oncology2021

Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial.

Chad Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.